N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141683 |
| CAS No | NA |
| Mol.F. | C25H23FN2O4 |
| Mol.Wt. | 434.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141684 |
| CAS No | NA |
| Mol.F. | C13H11ClN6O |
| Mol.Wt. | 302.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141685 |
| CAS No | NA |
| Mol.F. | C20H19N9O4S |
| Mol.Wt. | 481.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141686 |
| CAS No | NA |
| Mol.F. | C20H20N8O3S |
| Mol.Wt. | 452.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141687 |
| CAS No | NA |
| Mol.F. | C21H26N2O6 |
| Mol.Wt. | 402.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141688 |
| CAS No | 32863-63-1 |
| Mol.F. | C13H13ClN4O |
| Mol.Wt. | 276.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141689 |
| CAS No | NA |
| Mol.F. | C13H16FN3O4 |
| Mol.Wt. | 297.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141690 |
| CAS No | NA |
| Mol.F. | C15H18FN3O4 |
| Mol.Wt. | 323.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141691 |
| CAS No | NA |
| Mol.F. | C14H18FN3O4 |
| Mol.Wt. | 311.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141692 |
| CAS No | NA |
| Mol.F. | C13H15FN2O5 |
| Mol.Wt. | 298.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141693 |
| CAS No | NA |
| Mol.F. | C20H17F4N5O3 |
| Mol.Wt. | 451.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141694 |
| CAS No | NA |
| Mol.F. | C21H15F4N5O3S |
| Mol.Wt. | 493.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141695 |
| CAS No | NA |
| Mol.F. | C7H8N2O2S |
| Mol.Wt. | 184.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141696 |
| CAS No | NA |
| Mol.F. | C9H10N2O3S |
| Mol.Wt. | 226.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141697 |
| CAS No | NA |
| Mol.F. | C21H24N2O4 |
| Mol.Wt. | 368.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141698 |
| CAS No | NA |
| Mol.F. | C15H20N4O3S3 |
| Mol.Wt. | 400.5 |
| INV STATUS | CUSTOM SYNTHESIS |